Modular Medical Announces Completion Of Market Research Study With Cardiometabolic Patient Insights Firm Thrivable To Explore Perceptions Of Modular Medical's Pivot Insulin Delivery System Across Diabetic Patients

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced the completion of an extensive market research study conducted in partnership with Thrivable, a cardiometabolic patient insights company that designs and conducts research with highly engaged members of the diabetes community.

Thrivable combines a proprietary community of people living with cardiometabolic conditions with a dedicated research team to generate patient-centric insights through direct engagement. Thrivable helps healthcare companies better understand the daily experiences, burdens, and unmet needs of people living with diabetes and other chronic conditions.